Rigel Pharmaceuticals Inc (RIGL)

Sales/Maturities of Investments

$143.01M

TTM · Period ending: · USD

RIGL logo

RIGL Sales/Maturities of Investments

Latest reported$143.01M
RIGL TTM Sales/Maturities of Investments ($29.59M → $143.01M)
High-resolution chart · PNG

RIGL sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
143,007,000
65,974,000
61,129,000
54,330,000
39,600,000
42,550,000
39,700,000
38,950,000
41,200,000
34,250,000
41,650,000
56,816,000
77,983,000
87,028,000
101,228,000
110,912,000
82,894,000
80,000,000
62,050,000
58,450,000
97,465,000
103,914,000
130,434,000
141,004,000
141,271,000
142,371,000
123,126,000
115,406,000
99,175,000
94,591,000
104,066,000
91,405,000
93,887,000
92,926,000
96,820,000
101,940,000
100,281,000
120,198,000
128,650,000
160,856,000
193,560,000
178,338,000
196,862,000
205,911,000
201,800,000
250,950,000
281,705,000
274,057,000
302,117,000
345,326,000
382,447,000
411,179,000
406,988,000
433,435,000
439,724,000
536,263,000
545,284,000
471,605,000
415,493,000
302,116,000
285,284,000
256,556,000
216,249,000
177,948,000
125,524,000
129,488,000
139,391,000
148,665,000
195,042,000
186,615,000
170,122,000
175,357,000
137,950,000
128,915,000
127,508,000
117,779,000
117,589,000
109,806,000
89,987,000
73,781,000
75,235,000
79,172,000
89,227,000
101,485,000
90,936,000
81,431,000
72,176,000
46,835,000
29,643,000
15,493,000
5,243,000
243,000
28,514,000
40,964,000
47,839,000
58,939,000
44,950,000
32,500,000
29,590,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.